Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-09

Clinical Trial Update: Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results show efficacy and safety data for Cipros 20 Association in treating dyslipidemias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cipros 20 Association

Snippet

Sponsor: EMS | Conditions: Dyslipidemias | Phase 3 | Status: COMPLETED